reglab/housing_qa huggingface dataset:
MD. Health Occupations Code Ann. §  12-501 (2021)
2021 Maryland Statutes|Health Occupations|Title 12 - Pharmacists and Pharmacies|Subtitle 5 - Practice of Pharmacy and Operation of Pharmacies|Section 12-501 - Refusal to Dispense or Refill Prescription

    (a)    A pharmacist may refuse to dispense or refill a prescription if the decision is based on professional judgment, experience, knowledge, or available reference materials.    (b)    (1)    Except as provided in paragraph (2) of this subsection, if a pharmacist refuses to dispense or refill a prescription, the pharmacist shall, to the extent practicable, notify the authorized prescriber that the prescription or refill was refused within 72 hours after the refusal.        (2)    Paragraph (1) of this subsection does not apply if a pharmacist is unable to determine the name of the authorized prescriber.
MD. Health Occupations Code Ann. §  12-502 (2021)
2021 Maryland Statutes|Health Occupations|Title 12 - Pharmacists and Pharmacies|Subtitle 5 - Practice of Pharmacy and Operation of Pharmacies|Section 12-502 - Pharmaceutical Information

    (a)    In the operation of a pharmacy, only a licensed pharmacist or an individual engaging in a professional experience program and acting under the direct supervision of a licensed pharmacist may provide information to the public or a health care practitioner concerning prescription or nonprescription drugs or devices including information as to their therapeutic values, potential side effects, and use in the treatment and prevention of diseases.    (b)    A licensed pharmacist shall give a patient who requests, in person or by telephone, the current price of a prescription drug or device that the pharmacy offers for sale to the public.
MD. Health Occupations Code Ann. §  12-503 (2021)
2021 Maryland Statutes|Health Occupations|Title 12 - Pharmacists and Pharmacies|Subtitle 5 - Practice of Pharmacy and Operation of Pharmacies|Section 12-503 - Dating of Prescription by Authorized Prescriber; Time Limit for Filling Prescription

    (a)    An authorized prescriber who issues a prescription shall indicate on the prescription the date of its issuance.    (b)    Unless otherwise instructed by the authorized prescriber who issues the prescription, a pharmacist may not dispense any drug or device on a prescription presented more than 120 days after the date the prescription was issued.
MD. Health Occupations Code Ann. §  12-504.1 (2021)
2021 Maryland Statutes|Health Occupations|Title 12 - Pharmacists and Pharmacies|Subtitle 5 - Practice of Pharmacy and Operation of Pharmacies|Section 12-504.1 - Dispensing Biological Products

    (a)    Except as provided in subsection (d) of this section, within 5 business days after dispensing a biological product to a patient, the dispensing pharmacist or the pharmacist’s designee shall communicate the specific biological product dispensed, including the name and manufacturer of the biological product, to the prescriber.    (b)    Except as provided in subsection (c) of this section:        (1)    The communication required under subsection (a) of this section shall be provided by making an entry that is electronically accessible to the prescriber through:            (i)    An interoperable electronic medical records system;            (ii)    An electronic prescribing technology;            (iii)    A pharmacy benefits management system; or            (iv)    A pharmacy record; and        (2)    Making an entry through a mechanism listed in paragraph (1) of this subsection is presumed to provide the communication to the prescriber required under subsection (a) of this section.    (c)    If the mechanisms listed in subsection (b)(1) of this section are not available, the communication required under subsection (a) of this section may be provided by facsimile, telephone, electronic transmission, or other means.    (d)    The communication requirement under subsection (a) of this section does not apply if:        (1)    The United States Food and Drug Administration has not approved an interchangeable biological product for the biological product prescribed to the patient; or        (2)    A refill prescription is not changed from the biological product dispensed on the most recent filling of the prescription.
MD. Health Occupations Code Ann. §  12-505 (2021)
2021 Maryland Statutes|Health Occupations|Title 12 - Pharmacists and Pharmacies|Subtitle 5 - Practice of Pharmacy and Operation of Pharmacies|Section 12-505 - Labeling Requirements for Prescription Medicines

    (a)    Except for a drug or device dispensed to an inpatient in a hospital or related institution, each container of a drug or device dispensed shall be labeled in accordance with this section.    (b)    In addition to any other information required by law, the label shall include:        (1)    The date the prescription is filled; and        (2)    Unless otherwise required by the prescriber:            (i)    An expiration date of the drugs or devices which shall be the lesser of:                1.    1 year from the date of dispensing;                2.    The month and year when the drugs or devices expire;                3.    The appropriate expiration date for repackaged drugs or devices; or                4.    A shorter period as determined by the pharmacist;            (ii)    Any appropriate special handling instructions regarding proper storage of the drugs or devices; and            (iii)    Subject to the provisions of subsection (c) of this section, the name and strength of the drugs or devices.    (c)    (1)    Except as provided in paragraph (2) of this subsection, the label shall indicate the same name for the drug or device as that used by the authorized prescriber.        (2)    If, under § 12-504 of this subtitle, the pharmacist substitutes a drug or device product for that named by the authorized prescriber, the label shall indicate both the name of the drug or device product and the name of the manufacturer or distributor of the drug or device dispensed.    (d)    (1)    Except as provided in this subsection, if an authorized prescriber dispenses a drug or device, the prescriber shall label each container of the drug or device.        (2)    In addition to any other information required by law, the authorized prescriber shall include on the label:            (i)    The name and strength of the drug or device;            (ii)    The date the prescription is dispensed;            (iii)    An expiration date of the drug or device which shall be the lesser of:                1.    1 year from the date of dispensing;                2.    The month and year when the drug or device expires; or                3.    A shorter period as determined by the authorized prescriber; and            (iv)    Any appropriate special handling instructions regarding proper storage of the drug or device.        (3)    The labeling requirements of this subsection do not apply if the authorized prescriber dispenses the drug or device:            (i)    To an inpatient in a hospital or related institution;            (ii)    In an emergency situation; or            (iii)    As a sample drug or device dispensed in the regular course of the authorized prescriber’s practice.    (e)    So long as any of the original contents remain in the container, a person may not alter, deface, or remove any label required by this section.
MD. Health Occupations Code Ann. §  12-506 (2021)
2021 Maryland Statutes|Health Occupations|Title 12 - Pharmacists and Pharmacies|Subtitle 5 - Practice of Pharmacy and Operation of Pharmacies|Section 12-506 - Guidelines for Unauthorized Refills

    (a)    A pharmacist may refill a prescription for a drug or device for which the refill has not been authorized if:        (1)    The pharmacist:            (i)    Attempts to obtain an authorization from the authorized prescriber; and            (ii)    Is not able readily to obtain the authorization;        (2)    The refill of the prescription is not for a controlled dangerous substance;        (3)    The drug or device is essential to the maintenance of life;        (4)    (i)    The drug or device is essential to the continuation of therapy in chronic conditions; and            (ii)    In the pharmacist’s professional judgment, the interruption of the therapy reasonably might produce an undesirable health consequence, be detrimental to the patient’s welfare, or cause physical or mental discomfort;        (5)    The pharmacist:            (i)    Enters on the back of the prescription or on another appropriate uniformly maintained, readily retrievable record, such as a medication record, the date and the quantity of the drug or device dispensed; and            (ii)    Signs or initials the record; and        (6)    The pharmacist notifies the authorized prescriber of the refill of the prescription within 72 hours of dispensing the drug or device.    (b)    If a pharmacist refills a prescription under subsection (a) of this section, the pharmacist may provide only 1 refill of the prescription and the refill quantity dispensed shall be in conformity with the prescriber’s directions for use and may not exceed a 14-day supply or unit of use.    (c)    If the federal or a state government declares a state of emergency, a pharmacist working in Maryland may refill a prescription for a drug for which the refill has not been authorized if:        (1)    As a result of the emergency, the pharmacist is unable to obtain an authorization from the authorized prescriber;        (2)    The refill of the prescription is not for a controlled dangerous substance;        (3)    The quantity dispensed does not exceed a 30–day supply or unit of use; and        (4)    The pharmacist notifies the authorized prescriber of the refill of the prescription within 7 days of dispensing the drug.
MD. Health Occupations Code Ann. §  12-507 (2021)
2021 Maryland Statutes|Health Occupations|Title 12 - Pharmacists and Pharmacies|Subtitle 5 - Practice of Pharmacy and Operation of Pharmacies|Section 12-507 - Consultation With Medical Assistance Recipients and Caregivers; Records

    (a)    A pharmacist who provides prescription services to medical assistance recipients shall offer to discuss with each medical assistance recipient or caregiver who presents a prescription order for outpatient drugs any matter which, in the exercise of the pharmacist’s professional judgment, the pharmacist deems significant, which may include the following:        (1)    The name and description of the medication;        (2)    The route, dosage form, dosage, route of administration, and duration of drug therapy;        (3)    Special directions and precautions for preparation, administration, and use by the patient;        (4)    Common severe side or adverse effects or interactions and therapeutic contraindications that may be encountered, including their avoidance, and the action required if they occur;        (5)    Techniques for self-monitoring drug therapy;        (6)    Proper storage;        (7)    Prescription refill information; and        (8)    Action to be taken in the event of a missed dose.    (b)    The offer to discuss may be made in the manner determined by the professional judgment of the pharmacist, which shall include either:        (1)    A face-to-face communication with the pharmacist; or        (2)    At least 2 of the following:            (i)    A sign posted so it can be seen by patients;            (ii)    A notation affixed to or written on the bag in which the prescription is to be dispensed;            (iii)    A notation contained on the prescription container; or            (iv)    Communication by telephone.    (c)    Nothing in this section shall be construed as requiring a pharmacist to provide consultation if the medical assistance recipient or caregiver refuses the consultation.    (d)    A pharmacist must make a reasonable effort to obtain, record, and maintain, at the individual pharmacy, at least the following information regarding a medical assistance recipient:        (1)    Name, address, telephone number, date of birth or age, and gender;        (2)    Individual history when significant, including disease state or states, known allergies and drug reactions, and a comprehensive list of medications and relevant devices; and        (3)    Pharmacist comments relevant to the individual’s drug therapy which may be recorded either manually or electronically in the patient’s profile.    (e)    This section shall apply only to medical assistance recipients presenting prescriptions for covered outpatient drugs.    (f)    The requirements of this section do not apply to refill prescriptions.    (g)    The Secretary, after consultation with the Maryland Pharmacists Association and the Maryland Association of Chain Drug Stores, shall adopt regulations in accordance with pharmacy practices in Maryland to implement the provisions of this section.
MD. Health Occupations Code Ann. §  12-508 (2021)
2021 Maryland Statutes|Health Occupations|Title 12 - Pharmacists and Pharmacies|Subtitle 5 - Practice of Pharmacy and Operation of Pharmacies|Section 12-508 - Administration of Vaccinations

    (a)    (1)    A pharmacist may administer an influenza vaccination to an individual who is at least 9 years old, in accordance with regulations adopted by the Board, in consultation with the Department.        (2)    A pharmacist may administer a vaccination that is listed in the Centers for Disease Control and Prevention’s Recommended Immunization Schedule to an individual who:            (i)    Is at least 11 years old but under the age of 18 years; and            (ii)    Has a prescription from an authorized prescriber.        (3)    (i)    Subject to subparagraph (ii) of this paragraph, a pharmacist may administer to an adult a vaccination that is:                1.    Listed in the Centers for Disease Control and Prevention’s Recommended Immunization Schedule; or                2.    Recommended in the Centers for Disease Control and Prevention’s Health Information for International Travel.            (ii)    A pharmacist shall administer a vaccination under subparagraph (i) of this paragraph under a written protocol that:                1.    Is vaccine specific; and                2.    Meets criteria established by the Department, in consultation with the Board, the Board of Physicians, and the Board of Nursing, in regulation.        (4)    A pharmacist shall:            (i)    Report all vaccinations administered by the pharmacist to the ImmuNet Program established under § 18–109 of the Health – General Article;            (ii)    If the vaccination has been administered in accordance with a prescription, document at least one effort to inform the individual’s authorized prescriber that the vaccination has been administered; and            (iii)    For a vaccination administered under paragraph (2) or (3) of this subsection, if the authorized prescriber is not the individual’s primary care provider or if the vaccination has not been administered in accordance with a prescription, document at least one effort to inform the individual’s primary care provider or other usual source of care that the vaccination has been administered.    (b)    The Board shall:        (1)    Set reasonable fees for the administration of vaccinations under this section; and        (2)    Adopt regulations that require a pharmacist to submit a registration form to the Board that includes verification that the pharmacist:            (i)    Has successfully completed a certification course approved by the Board that included instruction in the guidelines and recommendations of the Centers for Disease Control and Prevention regarding vaccinations; and            (ii)    Is certified in basic cardiopulmonary resuscitation and obtained the certification through in–person classroom instruction.
MD. Health Occupations Code Ann. §  12-509 (2021)
2021 Maryland Statutes|Health Occupations|Title 12 - Pharmacists and Pharmacies|Subtitle 5 - Practice of Pharmacy and Operation of Pharmacies|Section 12-509 - Administration of Drugs

    In addition to the authority granted to a pharmacist under § 12–508 of this subtitle, a pharmacist, in accordance with regulations adopted by the Board, may administer a self–administered drug to a patient that is prescribed by an authorized prescriber.
MD. Health Occupations Code Ann. §  12-510 (2021)
2021 Maryland Statutes|Health Occupations|Title 12 - Pharmacists and Pharmacies|Subtitle 5 - Practice of Pharmacy and Operation of Pharmacies|Section 12-510 - Compounded Nonsterile or Sterile Preparations

    (a)    Except as provided in subsection (b) of this section, a pharmacist may provide compounded nonsterile preparations or compounded sterile preparations without a patient–specific prescription to a licensed veterinarian who intends to dispense the compounded nonsterile preparations or compounded sterile preparations in accordance with § 2–313(c) of the Agriculture Article if the pharmacist:        (1)    Complies with USP 795 or USP 797, as applicable;        (2)    Labels the compounded nonsterile preparations or compounded sterile preparations with:            (i)    The name and strength of the compounded nonsterile preparations or compounded sterile preparations or a list of the active ingredients and the strength of the active ingredients in the compounded nonsterile preparations or compounded sterile preparations;            (ii)    An appropriate beyond–use date as determined by the pharmacist in accordance with USP–NF standards for pharmacy compounding;            (iii)    The quantity of compounded nonsterile preparations or compounded sterile preparations; and            (iv)    The name, address, and license number of the pharmacy; and        (3)    Complies with applicable federal law and regulations.    (b)    (1)    This subsection does not apply to dispensing compounded nonsterile preparations or compounded sterile preparations dispensed for a patient–specific prescription.        (2)    A pharmacy may not provide compounded nonsterile preparations or compounded sterile preparations compounded using bulk drug substances to a licensed veterinarian:            (i)    In an amount greater than 10% of the total amount of drug products sold or dispensed from the pharmacy; or            (ii)    If the compounded nonsterile preparations or compounded sterile preparations are copies or close approximations to products approved by the federal Food and Drug Administration.        (3)    For purposes of the limitation established in paragraph (2)(i) of this subsection:            (i)    The calculation shall be made on an annual basis and use the number of dosage units sold or dispensed; and            (ii)    For nonresident pharmacies, the total amount of drug products sold or dispensed shall be the pharmacy’s total business within the State.
MD. Health Occupations Code Ann. §  12-512 (2021)
2021 Maryland Statutes|Health Occupations|Title 12 - Pharmacists and Pharmacies|Subtitle 5 - Practice of Pharmacy and Operation of Pharmacies|Section 12-512 - Single Dispensing of Prescription Drugs by Pharmacist

    (a)    In this section, “authorized prescriber” has the meaning stated in § 12–101 of this title.    (b)    This section does not apply to:        (1)    A controlled dangerous substance as defined in § 5–101 of the Criminal Law Article; or        (2)    The first prescription or change in a prescription for a drug that an authorized prescriber prescribes for a patient.    (c)    Except as provided in subsection (d) of this section, a pharmacist may dispense, in a single dispensing and exercising the professional judgment of the pharmacist, a quantity of a prescription drug that:        (1)    Is up to the total number of dosage units authorized by the prescriber on the original prescription and any refills of the prescription;        (2)    Except for a contraceptive dispensed on or after January 1, 2020, does not exceed a 90–day supply of the prescription drug; and        (3)    For a contraceptive dispensed on or after January 1, 2020, does not exceed a 12–month supply of the prescription drug.    (d)    A pharmacist may not dispense, in a single dose, a quantity of a prescription drug that exceeds the limit prescribed by a prescriber when the prescriber has indicated that the prescription be dispensed only as prescribed.
MD. Health Occupations Code Ann. §  12-601 (2021)
2021 Maryland Statutes|Health Occupations|Title 12 - Pharmacists and Pharmacies|Subtitle 6 - Board Regulation of Drugs, Medicines, and Other Products|Section 12-601 - Disciplinary Actions

    (a)    Subject to the hearing provisions of § 12–315 of this title, for a violation of  this subtitle, Subtitle 6C of this title, or any regulation adopted under Subtitle 6C of this title, the Board may:        (1)    Deny a permit to an applicant;        (2)    Reprimand a permit holder;        (3)    Place a permit holder on probation; or        (4)    Suspend or revoke a permit.    (b)    A person aggrieved by a final action of the Board under this subtitle or Subtitle 6C of this title may appeal as provided under Title 10, Subtitle 2 of the State Government Article.
MD. Health Occupations Code Ann. §  12-604 (2021)
2021 Maryland Statutes|Health Occupations|Title 12 - Pharmacists and Pharmacies|Subtitle 6 - Board Regulation of Drugs, Medicines, and Other Products|Section 12-604 - General Power to Inspect Drugs, Medicines, and Other Products

    (a)    The Secretary, the Board, or the agents of either, during business hours, may:        (1)    Enter any place where drugs, devices, diagnostics, cosmetics, dentifrices, domestic remedies, or toilet articles are manufactured, packaged, stocked, or offered for sale; and        (2)    Inspect the drugs, devices, diagnostics, cosmetics, dentifrices, domestic remedies, and toilet articles there.    (b)    (1)    A pharmacy in this State issued a permit by the Board and subject to inspection under subsection (a) of this section shall be inspected annually.        (2)    A nonresident pharmacy:            (i)    Is subject to inspection under subsection (a) of this section by the Secretary, the Board, or the agents of either; and            (ii)    On application for and renewal of a pharmacy permit in this State, shall submit a copy of the most recent inspection report resulting from an inspection conducted by the regulatory or licensing agency of the state in which the nonresident pharmacy is located.    (c)    A person may not hinder an inspection conducted under this section.